A clinical study by Panich et al. [92] identified Activating Transcription Factor 3 (ATF3) as a potential early marker of sepsis-AKI detected within urinary sEVs collected from a cohort of patients with sepsis-AKI compared to those with sepsis without AKI and healthy controls. This evidence concerns the gene ATF3 and acute kidney injury.